Fábio Franke
- Pulmonary and Respiratory Medicine top 1%
- Oncology top 2%
- Molecular Biology
- Cancer Research top 5%
- Genetics top 5%
- Co-authors
- Carlos H. BarriosLucio CrinòPasi A. JänneAlice T. ShawPaul D. SmithG. JeanninJosé Rodrigues PereiraLynda Grinsted
- Topics
- Advanced Breast Cancer Therapies (14 papers)Lung Cancer Treatments and Mutations (14 papers)Cancer Immunotherapy and Biomarkers (10 papers)
- Journals
- New England Journal of MedicineJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesBrazilGermany
In The Last Decade
Fábio Franke
51 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Pulmonary and Respiratory Medicine 1.4k
- Oncology 1.3k
- Molecular Biology 558
- Cancer Research 535
- Genetics 183
Countries citing papers authored by Fábio Franke
This map shows the geographic impact of Fábio Franke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fábio Franke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fábio Franke more than expected).
Fields of papers citing papers by Fábio Franke
This network shows the impact of papers produced by Fábio Franke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fábio Franke. The network helps show where Fábio Franke may publish in the future.
Co-authorship network of co-authors of Fábio Franke
This figure shows the co-authorship network connecting the top 25 collaborators of Fábio Franke. A scholar is included among the top collaborators of Fábio Franke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fábio Franke. Fábio Franke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 3 | |
| 4 | 2 | |
| 5 | 27 | |
| 6 | 8 | |
| 7 | 4 | |
| 8 | 64 | |
| 9 | 1 | |
| 10 | 24 | |
| 11 | 6 | |
| 12 | 34 | |
| 13 | Phase III, randomized, double-blind, placebo-controlled study of ribociclib (LEE011) in combination with either tamoxifen and goserelin or a non-steroidal aromatase inhibitor (NSAI) and goserelin for the treatment of premenopausal women with HR+, HER2- advanced breast cancer (aBC): MONALEESA-7. | 6 |
| 14 | 59 | |
| 15 | Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 studybreakdown → | 512 |
| 16 | 56 | |
| 17 | 50 | |
| 18 | 81 | |
| 19 | 10 | |
| 20 | 13 |
About Fábio Franke
Fábio Franke is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 54 papers that have together received 2.0k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (14 papers), Lung Cancer Treatments and Mutations (14 papers) and Cancer Immunotherapy and Biomarkers (10 papers). The work is most often cited by research in Oncology (1.3k citations), Pulmonary and Respiratory Medicine (1.4k citations) and Cancer Research (535 citations). Fábio Franke has collaborated with scholars based in United States, Brazil and Germany. Frequent co-authors include Carlos H. Barrios, Lucio Crinò, Pasi A. Jänne, Alice T. Shaw, Paul D. Smith, G. Jeannin, José Rodrigues Pereira, Lynda Grinsted, Victoria Zazulina and Johan Vansteenkiste. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.